Myeloma Gene Therapy
Reports from University Hospital advance knowledge in myeloma gene therapy
Published in Cancer Law Weekly, September 6th, 2008
Research findings, 'Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma,' are discussed in a new report. "Angiogenesis plays an important role in the pathogenesis and progression in multiple myeloma (MM), and MM cells secrete vascular endothelial growth factor (VEGF), which further promotes proliferation of the tumor cells. Therefore, we evaluated the anti-myeloma effect of VEGF small interfering RNA (siRNA) silencing in MM cells and whether it can be augmented by the additional application of bortezomib directed against the 26S proteasome," scientists in Essen, Germany...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2008-09-06)
More Articles from Cancer Law Weekly
- Harvard School of Public Health
Cervical cancer prevention should focus on vaccinating adolescent girls - Acute Appendicitis
New acute appendicitis research from Erasmus University outlined - Adenocarcinoma
Research on adenocarcinoma described by T. Tsuzuki and colleagues - Angiogenesis
Studies from University of Helsinki add new findings in the area of angiogenesis - Apoptosis
Study findings on apoptosis are outlined in reports from University of Heidelberg - Basal Cell Cancer
New basal cell cancer research from University of Rochester described - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
